Company intelligence / Profile preview

Alfa Intes

Casoria, Campania, Italyalfaintes.it ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Alfa Intes is a leading Italian ophthalmological group with over six decades of experience. It operates across the value chain from R&D to manufacturing and commercialization of pharmaceuticals, medical devices, nutraceuticals, surgical equipment, and diagnostic instruments for eye care. Recent clinical studies support efficacy and safety for products like Diabec® in non-infectious uveitis complicated by macular oedema and diabetic retinopathy with macular oedema.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeMedical deviceNutraceuticals
Industry: Biotech

Drug pipeline

7 assets

Carnidrop

Unknown

6 more assets in the full pipeline.

Request access →

Partnerships

Long-standing partnerships with international distributors in over 37 countries; specific partners not named.

Beyond the preview

Go deeper on Alfa Intes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alfa Intes.

Explore the full profile